Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
S100P
REST API REST API
Homo sapiens
S100P is differentially expressed in 265 experiments: 147 organism parts: lung, placenta, ... (145 more);, 173 disease states: normal, colon carcinoma, ... (171 more);, 93 cell types 546 cell lines 38 compound treatments and 61 other conditions.
Orthologs S100P (Canis familiaris)   A9JRZ7_XENTR (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term protein binding, cytoplasm, magnesium ion binding, nucleus, calcium-dependent protein binding, calcium ion binding, endothelial cell migration
InterPro Term EF_HAND_2, S100_Ca-bd_sub, EF_hand_Ca-bd
UniProt Accession P25815
Search EB-eye ENSG00000163993
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-GEOD-6573, E-GEOD-1577, E-GEOD-7224, ... (28 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, ... (35 experiments)

Factor Value U/D Experiments
SW480
3
E-GEOD-18005, E-MEXP-1014, E-GEOD-2509
A549
2
E-GEOD-3202, E-GEOD-6013
BT-474
2
E-GEOD-3529, E-GEOD-5823
BT20
2
E-MTAB-37, E-MTAB-62
HCC1937
2
E-MTAB-37, E-MTAB-62
MCF-10A
2
E-TABM-420, E-GEOD-14990
540 more value(s).


Cell type

studied in E-GEOD-22529, E-GEOD-22373, E-MEXP-993, E-GEOD-13987, E-TABM-34, ... (47 experiments)

Factor Value U/D Experiments
CD8+ T cell
3
E-AFMX-5, E-GEOD-6740, E-MTAB-25
monocyte
1
3
E-GEOD-5099, E-GEOD-995, E-MEXP-2019, E-GEOD-22373
CD14+ monocyte
2
E-AFMX-5, E-MEXP-1600
CD33+ myeloid
2
E-AFMX-5, E-TABM-145
whole blood
2
E-MTAB-25, E-GEOD-3026
B cell
1
2
E-GEOD-3982, E-GEOD-7307, E-GEOD-13987
87 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-GEOD-1577, E-TABM-15, E-MTAB-62, ... (54 experiments)

Factor Value U/D Experiments
adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-MEXP-1331
gastric carcinoma
3
E-MTAB-37, E-GEOD-2685, E-GEOD-15460
lung adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-2514
colon carcinoma
1
3
E-MTAB-37, E-GEOD-3726, E-MTAB-62, E-MTAB-57
neuroblastoma
2
E-MTAB-62, E-MTAB-37
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
167 more value(s).


Compound treatment

studied in E-GEOD-571, E-GEOD-6907, E-TABM-782, E-GEOD-5099, E-MEXP-2590, ... (19 experiments)

Factor Value U/D Experiments
MCSF
1
E-GEOD-20484
ponasterone A
1
E-GEOD-3113
Cxcl12
1
E-GEOD-7307
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
vanadium pentoxide
1
E-GEOD-5339
DMSO
1
E-MEXP-1561
32 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-2171, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-994, E-MEXP-1251, ... (7 experiments)

Clinical treatment
studied in E-GEOD-2171

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-1614, E-GEOD-3140, E-MEXP-2359, E-MTAB-62

Dfs follow up
studied in E-GEOD-22541

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-2509, E-GEOD-22148, E-TABM-147, ... (8 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-6919

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-20847, E-GEOD-6431, E-GEOD-361 ... (5 experiments)

Genotype
studied in E-GEOD-1045, E-GEOD-2466, E-GEOD-21750, E-GEOD-22593, E-TABM-321, ... (10 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-TABM-127, E-GEOD-20504, E-MEXP-1446, E-GEOD-22278, ... (9 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-5764, E-GEOD-1926, E-MEXP-2069, ... (29 experiments)

Infection
studied in E-GEOD-9723

Injury
studied in E-GEOD-19743

Localisation of metastases
studied in E-GEOD-22541

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-AFMX-1, E-TABM-84

Original diagnosis
studied in E-GEOD-21521

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-22152, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, E-GEOD-7114, ... (6 experiments)

Progesterone receptor status
studied in E-GEOD-3494

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-20037 ... (5 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797, E-GEOD-18791

RNAi
studied in E-MEXP-1422, E-GEOD-12438, E-MEXP-101, E-MEXP-548, E-GEOD-3697, ... (7 experiments)

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995

Sex
studied in E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883, E-GEOD-11428

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-GEOD-1926, E-TABM-276

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-19815, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-3494, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.265 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM